Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight

globenewswire.com
INCY Mentioned as a key company in the JAK Inhibitors Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Incyte. ACRS Mentioned as a key company in the JAK Inhibitors Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Aclaris Therapeutics. TAK Mentioned as a key company in both the JAK Inhibitors Market and Psoriasis Market reports, which are part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Takeda. AZN Mentioned as a key company in the JAK Inhibitors Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for AstraZeneca. PFE Mentioned as a key company in the JAK Inhibitors Market, Over the Counter Drugs Market, Atopic Dermatitis Market, and Vitiligo Market reports, all part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Pfizer. GSK Mentioned as a key company in the JAK Inhibitors Market, Over the Counter Drugs Market, and Atopic Dermatitis Market reports, all part of the broader dermatological therapeutics market. The article does not provide specific sentiment for GlaxoSmithKline. JNJ Mentioned as a key company in the Over the Counter Drugs Market and Psoriasis Market reports, both part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Johnson & Johnson. NVS Mentioned as a key company in the Over the Counter Drugs Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Novartis. SNY Mentioned as a key company in the Over the Counter Drugs Market and Atopic Dermatitis Market reports, both part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Sanofi. BHC Mentioned as a key company in the Atopic Dermatitis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Bausch Health Companies Inc. REGN Mentioned as a key company in the Atopic Dermatitis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Regeneron Pharmaceuticals Inc. ABBV Mentioned as a key company in the Atopic Dermatitis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for AbbVie Inc. ALGN Mentioned as a key company in the Atopic Dermatitis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Allergan PLC. BMY Mentioned as a key company in the Atopic Dermatitis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Bristol-Myers Squibb Company. AMGN Mentioned as a key company in the Vitiligo Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Amgen. ARCT Mentioned as a key company in both the JAK Inhibitors Market and Vitiligo Market reports, both part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Arcutis Biotherapeutics. CANF Mentioned as a key company in the Psoriasis Market report, which is part of the broader dermatological therapeutics market. The article does not provide specific sentiment for Can-Fite BioPharma.

Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight New York, USA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight

The global dermatological therapeutics market is expected to grow steadily, driven by the rising prevalence of acne, psoriasis, atopic dermatitis, and other chronic skin disorders. Growing awareness of skin health and increasing demand for effective and targeted treatments are supporting market expansion. The adoption of biologics, JAK inhibitors, and other advanced therapies is further transforming the treatment landscape. In addition, increased healthcare spending, improved diagnosis, and ongoing pharmaceutical research and development are creating new opportunities for market growth.

DelveInsight’s Dermatological Therapeutics Market Insights report provides the current and forecast market analysis, individual leading dermatological therapeutics companies’ market shares, challenges, dermatological therapeutics market drivers, barriers, trends, and key dermatological therapeutics companies in the market.

Dermatological Therapeutics Market Summary

To read more about the future of the dermatological therapeutics market, get a snapshot @ https://www.delveinsight.com/report-store/dermatological-therapeutics-market

Key Factors Contributing to the Rise in Growth of the Dermatological Therapeutics Market

Get a sneak peek at the dermatological therapeutics market dynamics @ Dermatological Therapeutics Market Trends

Regional Dermatological Therapeutics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the dermatological therapeutics market, get a snapshot of the Dermatological Therapeutics Market Analysis

Recent Developmental Activities in the Dermatological Therapeutics Market

What is Dermatological Therapeutics?

Dermatological therapeutics refer to medicines and treatment approaches used to prevent, manage, and treat diseases and disorders affecting the skin, hair, nails, and associated tissues. These therapies address a broad range of conditions, including acne, psoriasis, atopic dermatitis, eczema, fungal infections, skin infections, alopecia, vitiligo, and skin cancers. Dermatological treatments include topical formulations such as creams, ointments, gels, and lotions, as well as oral drugs, injectable biologics, corticosteroids, retinoids, antibiotics, antifungals, immunomodulators, and targeted therapies. Advances in immunology, molecular biology, and drug-delivery technologies have further expanded the therapeutic landscape, particularly through the development of targeted biologics and small-molecule therapies for chronic inflammatory and autoimmune skin disorders.

Dermatological Therapeutics Market Assessment

Which MedTech key players in the dermatological therapeutics market are set to emerge as the trendsetter explore @ Dermatological Therapeutics Market Size

Table of Contents

Interested in knowing the dermatological therapeutics market share by 2034? Click to get a snapshot of the Top Dermatological Therapeutics Companies

Related Reports

JAK Inhibitors Market

JAK Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast – 2036 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key JAK inhibitors companies, including Incyte Corporation, Aclaris Therapeutics, Sareum, Takeda, AstraZeneca, Ajax Therapeutics, Pfizer, GSK, Dizal Pharmaceutical, Confluence Life Sciences, Celon Pharma, Arcutis Biotherapeutics, Reistone Biopharma, and others.

Over the Counter Drugs Market

Over the Counter Drugs Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key OTC drugs companies such as Johnson & Johsnon Services Inc., BAYER AG, Novartis, Sanofi-aventis U.S. LLC., Pfizer Inc., GlaxoSmithKline plc., Cipla Inc., Piramal Enterprises Limited, Duramed Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Dr. Reddy's Laboratories, Innovus Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc, Reckitt Benckiser Group PLC, Afaxys Pharma, LLC, FOUNDATION CONSUMER HEALTHCARE, Alcon Inc., Teva Pharmaceutical Industries, Sun Pharmaceutical Industries Ltd., and others.

Atopic Dermatitis Market

Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key atopic dermatitis companies including Bausch Health Companies Inc., GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharmaceuticals Inc., Evelo Biosciences, AbbVie Inc., Allergan PLC, Cara Therapeutics, Bristol-Myers Squibb Company, Sanofi S.A., LEO Pharma, and others.

Vitiligo Market

Vitiligo Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key vitiligo companies including Incyte Corporation, Amgen, Boston Pharmaceuticals, Arcutis Biotherapeutics, Pfizer, Dermavant Sciences, Clinuvel Pharmaceuticals, Celgene, TWi Biotechnology, AXIM Biotechnologies, Arrien Pharmaceuticals, and others.

Psoriasis Market

Psoriasis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psoriasis companies, including Takeda, Nimbus Therapeutics, Johnson & Johnson Innovative Medicine, Protagonist Therapeutics, Can-Fite BioPharma, Alumis, SFA Therapeutics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.